Summit Global Investments Novo Nordisk A S Transaction History

Summit Global Investments

$1.34 Billion
Q1 2024

A detailed history of Summit Global Investments transactions in Novo Nordisk A S stock. As of the latest transaction made, Summit Global Investments holds 27,799 shares of NVO stock, worth $3.97 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

27,799

Previous 24,310 14.35%

Holding current value

$3.97 Million

Previous $2.52 Million 41.91%

% of portfolio

0.27%

Previous 0.16%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$102.11 - $135.92 $356,261 - $474,224	3,489 Added 14.35%	27,799 $3.57 Million
Q4 2023 Feb 06, 2024	SELL	$87.78 - $105.45 $608,052 - $730,452	-6,927 Reduced 22.18%	24,310 $2.52 Million
Q3 2023 Oct 13, 2023	BUY	$90.94 - $199.54 $1.23 Million - $2.71 Million	13,570 Added 76.81%	31,237 $2.84 Million
Q2 2023 Jul 18, 2023	BUY	$155.98 - $172.65 $8,578 - $9,495	55 Added 0.31%	17,667 $2.86 Million
Q1 2023 May 04, 2023	BUY	$132.34 - $159.14 $317,748 - $382,095	2,401 Added 15.78%	17,612 $2.8 Million

Q4 2022 Jan 31, 2023	SELL	$102.55 - $135.33 $1.59 Million - $2.1 Million	-15,532 Reduced 50.52%	15,211 $2.06 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $470,873 - $577,868	4,942 Added 19.15%	30,743 $3.06 Million
Q2 2022 Aug 23, 2022	SELL	$103.24 - $121.81 $630,589 - $744,015	-6,108 Reduced 19.14%	25,801 $2.88 Million
Q1 2022 Apr 29, 2022	BUY	$93.1 - $112.54 $152,404 - $184,227	1,637 Added 5.41%	31,909 $3.54 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $191,951 - $234,394	2,002 Added 7.08%	30,272 $3.39 Million
Q3 2021 Nov 08, 2021	SELL	$84.42 - $106.62 $29,715 - $37,530	-352 Reduced 1.23%	28,270 $2.71 Million
Q2 2021 Jan 28, 2022	SELL	$67.66 - $84.76 $109,541 - $137,226	-1,619 Reduced 5.35%	28,622 $2.4 Million
Q1 2021 Jan 27, 2022	BUY	$67.06 - $75.82 $209,897 - $237,316	3,130 Added 11.55%	30,241 $2.04 Million
Q4 2020 Feb 11, 2021	BUY	$63.89 - $73.8 $402,826 - $465,309	6,305 Added 30.3%	27,111 $1.89 Million
Q3 2020 Nov 16, 2020	BUY	$63.69 - $70.22 $383,350 - $422,654	6,019 Added 40.7%	20,806 $1.45 Million
Q2 2020 Aug 11, 2020	BUY	$58.54 - $67.94 $183,522 - $212,991	3,135 Added 26.91%	14,787 $968,000
Q1 2020 May 14, 2020	SELL	$49.46 - $64.78 $165,839 - $217,207	-3,353 Reduced 22.35%	11,652 $701,000
Q4 2019 Feb 13, 2020	BUY	$49.86 - $58.26 $32,409 - $37,869	650 Added 4.53%	15,005 $868,000
Q3 2019 Nov 08, 2019	BUY	$47.54 - $53.43 $13,548 - $15,227	285 Added 2.03%	14,355 $742,000
Q2 2019 Aug 16, 2019	BUY	$46.79 - $52.47 $73,928 - $82,902	1,580 Added 12.65%	14,070 $718,000
Q1 2019 May 14, 2019	SELL	$46.36 - $52.63 $242,787 - $275,623	-5,237 Reduced 29.54%	12,490 $653,000
Q4 2018 Feb 08, 2019	BUY	$41.54 - $47.25 $83 - $94	2 Added 0.01%	17,727 $817,000
Q3 2018 Nov 15, 2018	BUY	$46.76 - $51.24 $144,254 - $158,075	3,085 Added 21.07%	17,725 $836,000
Q1 2018 May 03, 2018	BUY	$48.49 - $58.14 $709,893 - $851,169	14,640 New	14,640 $721,000

Others Institutions Holding NVO

# of Institutions

1,854

Shares Held

309M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $322B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.

Account

Summit Global Investments Novo Nordisk A S Transaction History